SCHEMBL5551104

SCHEMBL5551104

COc1cccc(C2CC(=O)c3c(cc(O)c(OC)c3O)O2)c1OC

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.69
▸ RAB9A P51151 2/20 0.69
▸ CYP19A1 P11511 4/20 0.60
▸ TAS2R31 P59538 1/20 0.58
▸ ABCG2 Q9UNQ0 2/20 0.53
▸ ABCB1 P08183 1/20 0.53
▸ CACNA1H O95180 2/20 0.48
▸ POLB P06746 2/20 0.48
▸ CRHBP P24387 1/20 0.48
▸ CRHR2 Q13324 1/20 0.48
▸ PLK1 P53350 1/20 0.48
▸ MMP2 P08253 1/20 0.48
▸ MMP9 P14780 1/20 0.48
▸ TP53 P04637 2/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ XDH P47989 2/20 0.47
▸ CYP1A1 P04798 2/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ CYP1B1 Q16678 2/20 0.47
▸ HPGD P15428 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30721031 0.89 NPC1 (0.71) NPC1RAB9ACYP19A1TAS2R31ABCG2
SCHEMBL20450286 0.85 NPC1 (0.69) NPC1RAB9ACYP19A1TAS2R31ABCG2
SCHEMBL26679501 0.82 CYP19A1 (0.72) CYP19A1ABCG2CYP3A4HPGDALDH1A1
Dihydrooroxylin A SCHEMBL12067042 0.81 NPC1 (1.00) NPC1RAB9ACYP19A1TAS2R31ABCG2
Dihydrooroxylin A SCHEMBL31682921 0.81 NPC1 (1.00) NPC1RAB9ACYP19A1TAS2R31ABCG2
SCHEMBL905614 0.81 NPC1 (0.73) NPC1RAB9ACYP19A1TAS2R31ABCG2
SCHEMBL27775449 0.79 NPC1 (0.82) NPC1RAB9ACYP19A1TAS2R31ABCG2
SCHEMBL30716844 0.78 NPC1 (0.77) NPC1RAB9ACYP19A1TAS2R31ABCG2
SCHEMBL782044 0.78 TAS2R31 (0.74) NPC1RAB9ACYP19A1TAS2R31ABCG2
SCHEMBL4225984 0.78 TAS2R31 (0.74) NPC1RAB9ACYP19A1TAS2R31ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765313-A2 COMPOUNDS FOR IMMUNOPOTENTIATION Novartis Vaccines and Diagnostics, Inc. (US) 2007-03-28 — — EP disclosed
WO-2006002422-A2 COMPOUNDS FOR IMMUNOPOTENTIATION NOVARTIS VACCINES AND DIAGNOSTICS INC. (US) 2006-01-05 — — WO disclosed
Send feedback